North Macedonia vs Tajikistan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
North Macedonia
0.2%
in 2024
Tajikistan
0.2%
in 2024
North Macedonia rank
99th
Tajikistan rank
99th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- North Macedonia
- Tajikistan
How they compare
North Macedonia currently reports 0.2% against 0.2% in Tajikistan, a difference of 0.0%.
Across all 10 years both countries report, Tajikistan has been ahead every year.
North Macedonia ranks 99th and Tajikistan ranks 99th of 247 countries.
Tajikistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Macedonia | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.3% | 0.2% | Tajikistan |
| 2020s | 0.1% | 0.2% | 0.1% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, North Macedonia or Tajikistan?
- North Macedonia, at 0.2% against 0.2% in Tajikistan as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between North Macedonia and Tajikistan?
- 0.0%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Tajikistan?
- 10 years are reported by both, from 2015 to 2024.
- How do North Macedonia and Tajikistan rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- North Macedonia ranks 99th and Tajikistan ranks 99th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.